Abstract
Immunoglobulin A (IgA) mediates mucosal responses to food antigens and the intestinal microbiome and has a known role in susceptibility to mucosal pathogens, celiac disease, inflammatory bowel disease, and IgA nephropathy. We performed genetic analyses of serum IgA levels in 41,263 individuals of diverse ancestries. We observed unexpected variability in IgA levels across major ancestral populations, with African ancestry being reproducibly associated with higher serum IgA levels compared to other ancestries. The trans-ethnic GWAS analysis identified 20 genome-wide significant loci associated with serum IgA levels, including nine known and 11 novel loci. Systematic co-localization analysis with blood and primary immune cell expression QTLs prioritized candidate genes for 14 of 20 loci. Most GWAS loci encoded genes that produce immune defects and IgA abnormalities when genetically manipulated in mice. We uncovered positive genetic correlations of serum IgA levels with IgA nephropathy, type 2 diabetes and body mass index, as well as negative genetic correlations with celiac disease, inflammatory bowel disease, several infections, and intestinal microbiome diversity. Our findings provide novel insights into the genetic regulation of IgA production and its potential role in human disease.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases grant numbers R01DK105124 and RC2DK116690. MESA and the MESA SHARe project are conducted and supported by the National Heart, Lung, and Blood Institute. Support for MESA is provided by contracts 75N92020D00001, HHSN268201500003I, N01-HC-95159, 75N92020D00005, N01-HC-95160, 75N92020D00002, N01-HC-95161, 75N92020D00003, N01-HC-95162, 75N92020D00006, N01-HC-95163, 75N92020D00004, N01-HC-95164, 75N92020D00007, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, UL1-TR-000040, UL1-TR-001079, UL1-TR-001420, UL1-TR-001881, and DK063491. Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-64278. The eMERGE network is funded by the National Human Genome Research Institute through the following grants: U01HG008657; U01HG008680; U01HG008685; U01HG008672; U01HG008666; U01HG006379; U01HG008679; U01HG008684; U01HG008673; U01HG008701; U01HG008676; U01HG008664; and U54MD007593.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All subjects provided informed consent to participate in genetic studies, and the Institutional Review Board (IRB) of Columbia University as well as local ethics review committees for each of the individual cohorts approved our study protocol.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The MESA SHARe genotype and phenotype data (including serum IgA levels measured in this study) are available through dbGAP, accession number phs000209.v13.p3. The Electronic Medical Records and Genomics-III (eMERGE-III) imputed genotype and phenotype data are available through dbGAP, accession number: phs001584.v2.p2. The UK Biobank genotype and phenotype data are available through the UK Biobank web portal. Genotype and phenotype data for all other cohorts is in the process of dbGAP submission (accession number pending). GWAS summary statistics will be available for download from http://www.columbiamedicine.org/divisions/kiryluk/study_gwas_stat.php at the time of publication. All data produced in the present study are available upon reasonable request to the authors.